Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283283 · ClinicalTrials.gov registry record · Phase 2
Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine
A Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,316
- Enrollment target
NCT00283283 is a Phase 2 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 1,316 participants.
The verdict
NCT00283283, a Phase 2 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,316 participants
- Enrollment target
Study Summary
This study compared full-dose Flu vaccine to half-dose Flu-vaccine during the 2004-2005 flu season.
Interventions
- BIOLOGICAL Fluzone® (Aventis Pasteur inactivated influenza vaccine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,316 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283283
The ClinicalTrials.gov registry entry for NCT00283283 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluzone® (Aventis Pasteur inactivated influenza vaccine) is the first listed.
NCT00283283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00283283 about?
NCT00283283 is a clinical study titled "Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine". This study compared full-dose Flu vaccine to half-dose Flu-vaccine during the 2004-2005 flu season.
What is the current status of trial NCT00283283?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,316 participants. The study started on 2004-11. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00283283?
The interventions under investigation include: Fluzone® (Aventis Pasteur inactivated influenza vaccine) (BIOLOGICAL).
Who is sponsoring clinical trial NCT00283283?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.